Positive result announcement from HOPE – 2 clinical trial for Duchenne Muscular Dystrophy by Capricor Pharmaceuticals

| July 29, 2020| Announcements

Positive result announcement from HOPE – 2 clinical trial for Duchenne Muscular Dystrophy by Capricor Pharmaceuticals

 

One year results show improved function of upper limbs.

Company’s intention is to meet with FDA for approval discussion.

For detailed information in the Press Release:

http://www.irdirect.net/prviewer/release/id/4322252

Scientific Revisal

Evgenia Oikonomidou – Scientific Advisor – Biochemist MSc

Last modified: July 29, 2020

Comments are closed.

↑